Unleashing the clinical power of T cells: CD19/CD3 bi-specific T cell engager (BiTE®) antibody construct blinatumomab as a potential therapy (Q38252698)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Unleashing the clinical power of T cells: CD19/CD3 bi-specific T cell engager (BiTE®) antibody construct blinatumomab as a potential therapy |
scientific article |
Statements
1 reference
Unleashing the clinical power of T cells: CD19/CD3 bi-specific T cell engager (BiTE®) antibody construct blinatumomab as a potential therapy (English)
1 reference
Zachary Zimmerman
1 reference
Tapan Maniar
1 reference
Dirk Nagorsen
1 reference
19 September 2014
1 reference
1 reference
27
1 reference
1
1 reference
31-37
1 reference
Identifiers
1 reference
1 reference